⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14222130 | 0.80 | — | — | |
| SCHEMBL13620676 | 0.79 | — | — | |
| SCHEMBL16067286 | 0.74 | — | — | |
| SCHEMBL14819115 | 0.74 | — | — | |
| SCHEMBL18272089 | 0.73 | — | — | |
| SCHEMBL13445272 | 0.72 | — | — | |
| SCHEMBL19249559 | 0.71 | — | — | |
| SCHEMBL13464101 | 0.70 | — | — | |
| SCHEMBL13902041 | 0.70 | — | — | |
| SCHEMBL15995089 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017070133-A9 | INTRACELLULAR DELIVERY COMPOUNDS | SORRENTO THERAPEUTICS, INC. (US) | 2017-06-15 | — | — | WO | disclosed |
| WO-2017070133-A1 | INTRACELLULAR DELIVERY COMPOUNDS | SORRENTO THERAPEUTICS, INC. (US) | 2017-04-27 | — | — | WO | disclosed |
| EP-2774915-A1 | New derivatives of resveratrol | Mattarei, Andrea (IT) | 2014-09-10 | — | — | EP | disclosed |
| US-20090286938-A1 | SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-11-19 | — | — | US | disclosed |